Biomedical Engineering Reference
In-Depth Information
35. He YJ, Brockmoller J, Schmidt H, Roots I, Kirchheiner J (2008) CYP2D6 ultrarapid metabolism
and morphine/codeine ratios in blood: was it codeine or heroin? J Anal Toxicol 32:178-182
36. Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J (2004) Codeine intoxi-
cation associated with ultrarapid CYP2D6 metabolism. N Engl J Med 351(27):1356-1358
37. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ (2006) Pharmacogenetics of morphine
poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 368(9536):704
38. Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G (2009) Codeine, ultrarapid-
metabolism genotype, and postoperative death. N Engl J Med 361(8):827-828
39. Voronov P, Przybylo HJ, Jagannathan N (2007) Apnea in a child after oral codeine: a genetic
variant - an ultra-rapid metabolizer. Paediatr Anaesth 17(7):684-687
40. Madadi P, Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder JS, Teitelbaum R, Karaskov T,
Aleksa K (2007) Safety of codeine during breastfeeding: fatal morphine poisoning in the
breastfed neonate of a mother prescribed codeine. Can Fam Physician 53(1):33-35
41. Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, Greenblatt DJ
(2003) Evaluation of 3¢ -azido-3 ¢-deoxythymidine, morphine, and codeine as probe substrates
for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and
influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31:1125-1133
42. Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, Miners JO (2000) Genetic
polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268; ethnic
diversity of alleles and potential clinical significance. Pharmacogenetics 10:679-685
43. Innocenti F, Lui W, Frackenthal D, Ramirez J, Chen P, Ye X, Wu X, Zhang W, Mirkov S, Das
S, Cook E Jr, Ratain MJ (2008) Single nucleotide polymorphism discovery and functional
assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet
Genomics 18:683-697
44. Lotsch J, Skarke C, Liefhold J, Geisslinger G (2004) Genetic predictors of the clinical response
to opioid analgesics. Clin Pharmacokinet 43(14):983-1013
45. Lötsch J, von Hentig N, Freynhagen R, Griessinger N, Zimmermann M, Doehring A,
Rohrbacher M, Sittl R, Geisslinger G (2009) Cross-sectional analysis of the influence of cur-
rently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Pharmacogenet Genomics 19(6):429-436
46. Campa D, Gioia A, Tomei A, Poli P, Barale R (2008) Association of ABCB1/MDR1 and OPRM1
gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 83(4):559-566
47. Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, Trégouet D, Descot C, Parc
Y, Lienhart A, Jaillon P, Becquemont L (2006) Environmental and genetic factors associated
with morphine response in the postoperative period. Clin Pharmacol Ther 79(4):316-324
48. Coles R, Kushnir MM, Nelson GJ, McMillin GA, Urry FM (2007) Simultaneous determination
of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in
urine, serum, plasma, whole blood, and meconium by LC-MS-MS. J Anal Toxicol 31(1):1-14
49. Bogusz MJ, Maier RD, Erkens M, Driessen S (1997) Determination of morphine and its 3- and
6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by
liquid chromatography atmospheric pressure chemical ionization mass spectrometry.
J Chromatogr B Biomed Sci Appl 703(1-2):115-127
50. Schänzle G, Li S, Mikus G, Hofmann U (1999) Rapid, highly sensitive method for the deter-
mination of morphine and its metabolites in body fluids by liquid chromatography-mass spec-
trometry. J Chromatogr B Biomed Sci Appl 721(1):55-65
51. Al-Asmari AI, Anderson RA (2007) Method for quantification of opioids and their metabolites
in autopsy blood by liquid chromatography-tandem mass spectrometry. J Anal Toxicol
31(7):394-408
52. Dahn T, Gunn J, Kriger S, Terrell AR (2010) Quantitation of morphine, codeine, hydrocodone,
hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine,
blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detec-
tion. Methods Mol Biol 603:411-422
